横浜市立大学 消化器内科学教室 - 2016/2/14-17 ECCO 2018 in Vienna ウィーンで開催されたEuropean Crohn's and Colitis Organisation Congress 2018にて,当教室から附属市民総合医療センター IBDセンター の西尾 匡史 大学院生が発表を行いました ...
![European Crohn´s and Colitis Organisation - ECCO - P653 The changing epidemiology of IBD in the western world: a population-based study from Denmark European Crohn´s and Colitis Organisation - ECCO - P653 The changing epidemiology of IBD in the western world: a population-based study from Denmark](https://cm.ecco-ibd.eu/cmAbstractSubmission/Content/cmabstsms/EC22/abstracts/0000000370/0000614990/Images/screenshot2021-11-19at95332p.png)
European Crohn´s and Colitis Organisation - ECCO - P653 The changing epidemiology of IBD in the western world: a population-based study from Denmark
![Patient Centricity in IBD Treatment: An Interview with Dr Corey Siegel at the 13th Congress of ECCO - European Medical Journal Patient Centricity in IBD Treatment: An Interview with Dr Corey Siegel at the 13th Congress of ECCO - European Medical Journal](https://emj.emg-health.com/wp-content/uploads/sites/2/2018/04/Patient-Centricity-in-IBD-Treatment-An-Interview-with-Dr-Corey-Siegel-at-the-13th-Congress-of-ECCO-940x564.jpg)
Patient Centricity in IBD Treatment: An Interview with Dr Corey Siegel at the 13th Congress of ECCO - European Medical Journal
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects
![PDF) N-ECCO Consensus statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis PDF) N-ECCO Consensus statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis](https://i1.rgstatic.net/publication/247156190_N-ECCO_Consensus_statements_on_the_European_nursing_roles_in_caring_for_patients_with_Crohn's_disease_or_ulcerative_colitis/links/5d1b6af0a6fdcc2462b92ebb/largepreview.png)
PDF) N-ECCO Consensus statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis
![PDF) Corrigendum: Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN PDF) Corrigendum: Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN](https://i1.rgstatic.net/publication/323832910_Corrigendum_Vedolizumab_in_Paediatric_Inflammatory_Bowel_Disease_A_Retrospective_Multi-Centre_Experience_From_the_Paediatric_IBD_Porto_Group_of_ESPGHAN/links/5acdfed2aca2723a33411e30/largepreview.png)
PDF) Corrigendum: Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN
![PDF) 2nd N-ECCO Consensus Statements on the European Nursing Roles in Caring for Patients with Crohn's Disease or Ulcerative Colitis PDF) 2nd N-ECCO Consensus Statements on the European Nursing Roles in Caring for Patients with Crohn's Disease or Ulcerative Colitis](https://i1.rgstatic.net/publication/323614047_2nd_N-ECCO_Consensus_Statements_on_the_European_Nursing_Roles_in_Caring_for_Patients_with_Crohn's_Disease_or_Ulcerative_Colitis/links/5ad0e854458515c60f4f34f3/largepreview.png)
PDF) 2nd N-ECCO Consensus Statements on the European Nursing Roles in Caring for Patients with Crohn's Disease or Ulcerative Colitis
![PDF) Placebo Effect on the Health-related Quality of Life of Inflammatory Bowel Disease Patients: A Systematic Review With Meta-analysis PDF) Placebo Effect on the Health-related Quality of Life of Inflammatory Bowel Disease Patients: A Systematic Review With Meta-analysis](https://i1.rgstatic.net/publication/326399984_Placebo_Effect_on_the_Health-related_Quality_of_Life_of_Inflammatory_Bowel_Disease_Patients_A_Systematic_Review_With_Meta-analysis/links/5df1f863a6fdcc28371a426d/largepreview.png)
PDF) Placebo Effect on the Health-related Quality of Life of Inflammatory Bowel Disease Patients: A Systematic Review With Meta-analysis
![PDF) P374 Non-alcoholic fatty liver disease in inflammatory bowel disease: Prevalence and risk factors PDF) P374 Non-alcoholic fatty liver disease in inflammatory bowel disease: Prevalence and risk factors](https://i1.rgstatic.net/publication/322894972_P374_Non-alcoholic_fatty_liver_disease_in_inflammatory_bowel_disease_Prevalence_and_risk_factors/links/5ac8d953a6fdcc8bfc823559/largepreview.png)